Skin Cancer Treatment Success Stories: Investigational WTX-124 Induces Remission for Man With Advanced cSCC May 21, 2025
Accropeutics’ Oral Selective TYK2/JAK1 Inhibitor Performs Well in Phase 2 Study of Moderate-to-Severe Plaque PsO May 21, 2025
Medicare Win: STRATA Skin Sciences Gains CPT Code Expansion for Excimer Laser Use in Skin Inflammatory Diseases May 20, 2025
HS Pipeline Watch: Zura Bio Launches Global Phase 2 Study of Its Dual IL-17A and BAFF Inhibitor in Adults With HS May 20, 2025
Residual Inflammation in Psoriasis Linked to Obesity, Fatty Liver Disease: Exploring Implications for Treatment May 20, 2025